FAIRWAY, Kan., March 31, 2020 /PRNewswire/ — Artio Medical, Inc. (Artio), a medical device company developing innovative products for the peripheral vascular and neurovascular markets, announced today it has closed an additional $8.8 million in Series A financing, bringing the total capital raised to date to more than $20 million. “Artio is developing a strong […]
Author: Ken Dropiewski
Former J&J/Biosense Webster Exec, Roy Tanaka, Joins S4 Medical’s Board of Directors
CLEVELAND, March 31, 2020 /PRNewswire/ — S4 Medical, an innovative medical device company focused on protecting the esophagus from damage during catheter ablation procedures, announced that Roy Tanaka has joined its board of directors, rounding out an impressive team. S4 Medical has developed a novel catheter called the “esolution” that utilizes a proprietary approach to […]
MediLynx Cardiac Monitoring, LLC introduces dedicated remote monitoring services based on its PocketECG® platform to support hospitals in managing COVID-19 patients in accordance with the latest FDA enforcement policy
PocketECG, MediLynx’s FDA approved remote monitoring systems: PocketECG Unified Arrhythmia Diagnostic System will be used for continuous streaming and analysis of full-disclosure ECG data, oxygen saturation, resting heart rate, patient symptoms and arrhythmia. The device is cleared by the FDA for the use of its data to analyze, measure and […]
Windtree Enters into Agreement with Lee’s Pharmaceutical for Non-Dilutive Funding of the Continued Development of AEROSURF®
WARRINGTON, Pa., March 31, 2020 /PRNewswire/ — Windtree Therapeutics, Inc. (OTCQB: WINT), a biotechnology and medical device company focused on developing drug product candidates and medical device technologies to address acute cardiovascular and pulmonary diseases, announces it has entered into a binding term sheet (the “Term Sheet”) with Lee’s Pharmaceutical Holdings (HK) Ltd (“Lee’s”) […]
Amgen Establishes Wholly-Owned Affiliate In Japan
Amgen K.K. Will Focus on Bringing Amgen’s Full Global Pipeline to Japanese Patients THOUSAND OAKS, Calif., March 31, 2020 /PRNewswire/ — Amgen (NASDAQ:AMGN) today announced that it has consummated the purchase from Astellas of 49% of shares of Amgen Astellas BioPharma K.K. (AABP), a joint venture between Amgen and Astellas established in […]
Shimadzu Medical Systems USA completes integration of CORE Medical Imaging Inc. to strengthen healthcare business organization in North America
TORRANCE, Calif., April 1, 2020 /PRNewswire/ — Shimadzu Medical Systems USA (hereinafter “SMS”), completes the integration of Core Medical Imaging Inc. (hereinafter “CMI”), a subsidiary of SMS into the company. CMI is starting its new operation under the name of SMS Northwest branch, located in Kenmore, WA and will continue to provide best-in-class healthcare solutions and service […]
Heart Health Intelligence Raises Funds for a Revolutionary In-Home Cardiovascular Monitoring Device
Company Closes its $2.2M Seed Round to Support Commercialization of The Heart Seat™ ROCHESTER, N.Y., April 01, 2020 (GLOBE NEWSWIRE) — Given the current COVID-19 pandemic, the ability to monitor cardiovascular health in the home has become critical to reduce the burden on healthcare systems around the world. According to […]
BIOCARDIA ANNOUNCES POSITIVE DSMB RECOMMENDATION TO CONTINUE PHASE III PIVOTAL CARDIAMP HEART FAILURE STUDY, AS PLANNED
Company to Host Conference Call with National Co-Principal Investigators Today at 4:15 p.m. ET to Provide Study Updates SAN CARLOS, Calif., March 31, 2020 (GLOBE NEWSWIRE) — BioCardia (Nasdaq: BCDA), a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, today announced that the independent Data Safety Monitoring Board (DSMB) […]
Acasti Pharma Submits FDA Meeting Request on Schedule, and FDA Meeting Expected in the Second Half of June
LAVAL, Québec, April 01, 2020 (GLOBE NEWSWIRE) — Acasti Pharma Inc. (“Acasti” or the “Company”) (NASDAQ: ACST – TSX-V: ACST), a biopharmaceutical innovator focused on the research, development and commercialization of its prescription drug candidate CaPre® (omega-3 phospholipid) for the treatment of severe hypertriglyceridemia, today announced that it has filed […]
Quantum Genomics Secured New Financing, Published its Financial Statements for Fiscal Year 2019 and Provides 2019 Highlights
Despite the current public health crisis and any financial consequences it may have, the fact that Quantum Genomics has secured new financing confirms that investors remain confident in its outlook. This round of financing, which includes a loan not to exceed €8 million and the issue of share subscription warrants, was […]



